Therapeutic strategies aimed at enhancing Klotho expression—such as the use of renin-angiotensin system inhibitors, statins, vitamin D receptor agonists and experimental gene therapy are currently being explored in the context of chronic kidney disease and age-related disorders (Table 1). The gene discussed is KL; the disease is chronic kidney disease.